Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Recent studies have suggested a bacterial role in the development of autoimmune disorders including type 1 diabetes (T1D). Over 30 billion nucleotide bases of Illumina shotgun metagenomic data were analyzed from stool samples collected from four pairs of matched T1D case-control subjects collected at the time of the development of T1D associated autoimmunity (i.e., autoantibodies). From these, approximately one million open reading frames were predicted and compared to the SEED protein database. Of the 3,849 functions identified in these samples, 144 and 797 were statistically more prevalent in cases and controls, respectively. Genes involved in carbohydrate metabolism, adhesions, motility, phages, prophages, sulfur metabolism, and stress responses were more abundant in cases while genes with roles in DNA and protein metabolism, aerobic respiration, and amino acid synthesis were more common in controls. These data suggest that increased adhesion and flagella synthesis in autoimmune subjects may be involved in triggering a T1D associated autoimmune response. Extensive differences in metabolic potential indicate that autoimmune subjects have a functionally aberrant microbiome. Mining 16S rRNA data from these datasets showed a higher proportion of butyrate-producing and mucin-degrading bacteria in controls compared to cases, while those bacteria that produce short chain fatty acids other than butyrate were higher in cases. Thus, a key rate-limiting step in butyrate synthesis is more abundant in controls. These data suggest that a consortium of lactate- and butyrate-producing bacteria in a healthy gut induce a sufficient amount of mucin synthesis to maintain gut integrity. In contrast, non-butyrate-producing lactate-utilizing bacteria prevent optimal mucin synthesis, as identified in autoimmune subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recent findings linked an aberrant microbiome, which is generally represented by diminished diversity, including fewer butyrate-producing (butyrate was shown to trigger mucin production and hence gut integrity) and mucin-degrading bacteria,241 to the development of autoimmunity in T1DM.242”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [241]
The cited source says what the claim attributes to it.
In the citing paper
“The authors further indicate that a decrease in Prevotella might be related with a reduction in mucin synthesis which is associated with increased gut permeability (Brown et al., 2011;Forsyth et al., 2011) intensifying the translocation of bacterial antigens.”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Abnormalities of GI motility might increase the occurrence of SIBO which is highly prevalent in PD patients (Brown et al., 2011;Sánchez-Ferro et al., 2015), even in recently diagnosed PD patients (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
Experimental — accuracy not yet measuredIn the citing paper
“As mentioned before, SIBO is highly prevalent in PD (Andrews et al., 2009;Brown et al., 2011) and PD patients that tested positive for SIBO are predisposed to worse motordysfunction (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
McCullagh, P., & Nelder, J. A. (1989) · doi:10.1007/978-1-4899-3242-6 · Cited by 16,836
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 3×
“At the phylum level and at p-values less than 0.001, Actinobacteria, Bacteroidetes, and Proteobacteria were higher in cases while Firmicutes, Fusobacteria, Tenericutes, and Verrucomicrobia were higher in controls.”
BackgroundInfluentialGeneralized, Linear, and Mixed Models
McCulloch, C. E., & Searle, S. R. (2000) · Wiley Series in Probability and Statistics · doi:10.1002/0471722073 · Cited by 2,994
Review article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721 · cited 1×
“Butyrate is known as an anti-inflammatory short chain fatty acid that contributes to colon health [31–33].”
BackgroundThe Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
Bach, J.-F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020100 · Cited by 2,687
Louis, P., & Flint, H. J. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01514.x · Cited by 2,179 · cited 1×
“Butyrate is known as an anti-inflammatory short chain fatty acid that contributes to colon health [31–33].”
BackgroundPeng, L., Li, Z.-R., Green, R. S., Holzmanr, I. R., & Lin, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.104638 · Cited by 2,130
Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium
Derrien, M., Vaughan, E. E., Plugge, C. M., & de Vos, W. M. (2004) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.02873-0 · Cited by 2,094 · cited 2×
“Perspective signatures of increased mucin synthesis in the gut may be the presence of Prevotella and Akkermansia as both genera are known to degrade mucin [30,39].”
BackgroundInnate immunity and intestinal microbiota in the development of Type 1 diabetes
Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., et al. (2008) · Nature · doi:10.1038/nature07336 · Cited by 1,921 · cited 2×
“Intestinal microbes and the innate immune system also interact to affect the development of diabetes in NOD mice [15].”
Background
Cited by
Items 501–600 of 777
Association of gut microbiota with idiopathic membranous nephropathy
Li, M., Wei, L., Sun, J., Zhu, Q., He, Y., Zhang, Y., Zhang, C., Lin, X., Zhao, R., & Du, X. (2022) · BMC Nephrology · doi:10.1186/s12882-022-02797-5 · Cited by 21
“flora is related to various diseases, such as inflammatory bowel disease [7,8], obesity [9], diabetes [10, 11], rheumatoid arthritis [12], atopic manifestations [13], liver sclerosis [14], cardiovascular disease [15], mental disease [16, 17], colorectal cancer [18, 19], and chronic kidney disease.”
BackgroundRegulatory T Cells: Therapeutic Opportunities in Uveitis
Lee, A. Y., & Foulsham, W. (2022) · Frontiers in Ophthalmology · doi:10.3389/fopht.2022.901144 · Cited by 15
Human Microbiota: A Neglected “Organ” in Precision Medicine
Bi, Y., Qin, N., & Yang, R. (2015) · doi:10.11979/idtm.201502005 · Cited by 15
Type 1 diabetes: Through the lens of human genome and metagenome interplay
Vahed, S. Z., Sani, H. M., Saadat, Y. R., Barzegari, A., & Omidi, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.052 · Cited by 17
Mistry, S., Riches, N. O., Gouripeddi, R., & Facelli, J. C. (2022) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2022.102461 · Cited by 18
Kompoura, V., Prapa, I., Vasilakopoulou, P. B., Mitropoulou, G., Nelios, G., Balafas, E., Kostomitsopoulos, N. G., Chiou, A., Karathanos, V. Τ., Bezirtzoglou, E., et al. (2023) · Metabolites · doi:10.3390/metabo13030415 · Cited by 14
“Regarding the presence of Tenericutes in T1D, lower relative abundances have been previously reported in humans with T1D and in non-obese T1D mice compared to non-diabetic controls [98,99].”
ResultSechovcová, H., Mahayri, T. M., Mrázek, J., Jarošíková, R., Husáková, J., Wosková, V., & Fejfarová, V. (2023) · Folia Microbiologica · doi:10.1007/s12223-023-01119-y · Cited by 15
“Other studies have found that instability in the microbiome and a high F/B ratio may be early diagnostic markers of pending autoimmune disorders such as type 1 diabetes (Giongo et al. 2011; Han et al. 2018).”
Gut Microbial Changes Associated With Obesity in Youth With Type 1 Diabetes
Ismail, H. M., Perera, D. N., Mandal, R. K., DiMeglio, L. A., Evans‐Molina, C., Hannon, T. S., Petrosino, J. F., Cregeen, S. J., & Schmidt, N. W. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae529 · Cited by 19
IGUDESMAN, D. A., Sweeney, M., Carroll, I. M., Mayer‐Davis, E. J., & Bulik, C. M. (2019) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2019.04.003 · Cited by 15
Diversity of Human-Associated Bifidobacterial Prophage Sequences
Buckley, D., Odamaki, T., Xiao, J., Mahony, J., van Sinderen, D., & Bottacini, F. (2021) · Microorganisms · doi:10.3390/microorganisms9122559 · Cited by 23
Buschard, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.876470 · Cited by 15
IGUDESMAN, D. A., Crandell, J., Corbin, K. D., Muntis, F. R., Zaharieva, D. P., Casu, A., Thomas, J. M., Bulik, C. M., Carroll, I. M., Pence, B. W., et al. (2022) · Current Developments in Nutrition · doi:10.1093/cdn/nzac107 · Cited by 17
“, increases or decreases in facets of carbohydrate metabolism) in individuals with T1D compared with controls without T1D (8, 9, 18).”
BackgroundRole of the gastrointestinal ecosystem in the development of type 1 diabetes
Daft, J. G., & Lorenz, R. G. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12282 · Cited by 16
“Human data has indicated that healthy subjects have a higher percentage of butyrate-producing and mucindegrading bacteria from the generas, Prevotella and Akkermansia, compared with T1D subjects (65).”
BackgroundResultResearch on Neonatal Microbiomes: What Neonatologists Need to Know
Sherman, M. P., Minnerly, J. C., Curtiss, W. J., Rangwala, S. H., & Kelley, S. T. (2013) · Neonatology · doi:10.1159/000354944 · Cited by 14
Chung, P.-H., Wu, Y.-Y., Chen, P.-H., Fung, C.-P., Hsu, C.-M., & Chen, L.-W. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.05.013 · Cited by 16
Correlating the Gut Microbiome to Health and Disease
Marques, T. M., Holster, S., Wall, R., König, J., Brummer, R. J., & de Vos, W. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802304-4.00012-8 · Cited by 16
Zhao, H., Zhou, J., Lu, H., Xi, A., Luo, M., Wang, K., Lv, H., Wang, H., Wang, P., Miao, J., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108388 · Cited by 14
Devaraj, S., Hemarajata, P., & Versalovic, J. A. (2013) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 28
Sohouli, M. H., Haghshenas, N., Pouladi, F., Sayyari, A., Olang, B., Găman, M., Kord‐Varkaneh, H., & Fatahi, S. (2020) · Nutrition · doi:10.1016/j.nut.2020.111069 · Cited by 13
Nutrition and the gut microbiome: a symbiotic dialogue influencing health and disease
Ray, S., & Shankaran, P. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1761992 · Cited by 16
Assessing the Ecotoxicity of Eight Widely Used Antibiotics on River Microbial Communities
Pino-Otín, M. R., Lorca, G., Langa, E., Roig, F. J., Terrado, E. M., & Ballestero, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316960 · Cited by 13
“Taxonomy was assigned using the Ribosomal Database Project (RDP) release 11 (Bacteria+Archaea combination) as the reference database [152].”
MethodGuo, K., Ye, J., Li, J., Huang, J., & Zhou, Z. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15658 · Cited by 12
“For external validation, we chose datasets from the gut MEtaGen-ome Atlas (gutMEGA) 25 between Finland T1D and normal populations 26 [searching for keywords such as ( ‘ Veillonellaceae ’ AND ‘ type 1 diabetes ’ ) at family level] and a Chinese population recruited from the National Clinical…”
The gut microbiome–helminth–immune axis in autoimmune diseases
Shimokawa, C. (2024) · Parasitology International · doi:10.1016/j.parint.2024.102985 · Cited by 14
Yarmohammadi, H., Soltanipur, M., Rezaei, M., Ejtahed, H., Raei, M., Razavi, A., Mirhosseini, S. M., Zangeneh, M., Doroud, D., Fateh, A., et al. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70071 · Cited by 13
Ebrahimi, S., Khatami, S., & Mesdaghi, M. (2021) · International Archives of Allergy and Immunology · doi:10.1159/000520510 · Cited by 15
Tamahane, V., Bhanushali, S., Shah, N., Gupta, A., Khadilkar, V. V., Gondhalekar, K. M., Khadilkar, A. V., & Shouche, Y. S. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13438 · Cited by 14
Different microbiomes are found in healthy breeder ducks and those with foot pad dermatitis
Qin, S., Bai, W. Q., Zhang, K., Ding, X., Bai, S., Wang, J. P., Peng, H., Yang, Y. F., Chen, C., & Zeng, Q. (2019) · Poultry Science · doi:10.3382/ps/pez456 · Cited by 12
“, 2013), type I diabetes (Brown et al., 2011), and constipation (Zhu et al.”
BackgroundMicrobial Ecosystem in Diabetes Mellitus: Consideration of the Gastrointestinal System
Yehualashet, A. S., & Yikna, B. B. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s304497 · Cited by 14
The kaleidoscope of autoimmunity – From genes to microbiome
Shoenfeld, Y., Ehrenfeld, M., & Perry, O. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.12.003 · Cited by 12
Martina, A., Felis, G. E., Corradi, M., Maffeis, C., Torriani, S., & Venema, K. (2019) · Beneficial Microbes · doi:10.3920/bm2018.0088 · Cited by 12
Antigen-specific T cell responses in autoimmune diabetes
Dwyer, A. J., Shaheen, Z. R., & Fife, B. T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1440045 · Cited by 17
Luppi, S., Aldegheri, L., Azzalini, E., Pacetti, E., Sebastiani, G. B., Fabiani, C., Robino, A., & Comar, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910611 · Cited by 14
“Healthy individuals were found to have a more functionally diverse microbiome compared to those with diabetes [67,71].”
BackgroundXu, W., Zhou, M., Yang, Z., Zheng, M., & Chen, Q. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1517976 · Cited by 11
Longitudinal change and causal relationship between gut microbiota and gestational diabetes mellitus
Wu, X., Liu, X., Tan, H., Song, J., Ma, S., & Tan, Y. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01737-1 · Cited by 12
“Moreover, as mucin-degrading bacteria, Prevotella may impair the integrity of the intestinal barrier [61], leading to increased levels of lipopolysaccharide entering the bloodstream, thereby influencing the immune system and causing low-grade inflammation [62, 63].”
Ismail, H. M., & Evans‐Molina, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.892291 · Cited by 12
Zheng, S., Luo, Y., Wang, J.-B., Chen, X.-M., Xu, Y., & Xiao, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116033 · Cited by 14
Gut microbiota: methodological aspects to describe taxonomy and functionality
Ngom‐Bru, C., & Barretto, C. (2012) · Briefings in Bioinformatics · doi:10.1093/bib/bbs019 · Cited by 15
“For instance, recent metagenomics studies in the field of gut microbiota are not only being applied to the description of metabolic capabilities, but also to the study of pathologies such as obesity [18] and diabetes [19], and even extended to the understanding of the human gut population of viruses [20].”
BackgroundGenomic Technologies in Medicine and Health
Rogers, Y.-H., & Zhang, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-420196-5.00002-2 · Cited by 17
An Early Life Mucosal Insult Temporarily Decreases Acute Oxazolone-Induced Inflammation in Mice
Bendtsen, K. M., Tougaard, P., & Hansen, A. K. (2018) · Inflammation · doi:10.1007/s10753-018-0790-y · Cited by 11
Zhang, S., Kang, T., Malacrinò, A., Zhang, Z., Zhang, Z., Lin, W., & Wu, H. (2024) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.13453 · Cited by 10
Talja, I., Kubo, A., Veijola, R., Knip, M., Simell, O., Ilonen, J., Vähä-Mäkilä, M., Sepp, E., Mikelsaar, M., Utt, M., et al. (2014) · Journal of Immunology Research · doi:10.1155/2014/325938 · Cited by 11
Self-citationChen, F., Cheng, G., Xu, Y., Wang, Y., Xia, Q., & Hu, S. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.00251 · Cited by 11
“The intestinal microbiota has been linked to several conditions including diabetes and inflammatory bowel disease (35, 36).”
BackgroundThe Effect of Probiotics on Various Diseases and their Therapeutic Role: An Update Review
Hashempour‐Baltork, F., Sheikh, M., Eskandarzadeh, S., Tarlak, F., Tripathi, A. D., Khosravi‐Darani, K., & САДАНОВ, А. К. (2021) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.15.3.17 · Cited by 11
Aljumaiah, M. M., Alonazi, M. A., Al-Dbass, A. M., Almnaizel, A. T., Alahmed, M., Soliman, D. A., & El-Ansary, A. K. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01912-9 · Cited by 12
Effect of low-dose radiation on thyroid function and the gut microbiota
Tong, J., Jiang, W., Yu, X., Wang, R., Lu, G., Gao, D., Lv, Z., & Li, D. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i38.5557 · Cited by 11
The Gut-Brain Axis in Autoimmune Diseases: Emerging Insights and Therapeutic Implications
Khawar, M. M., Ijaz, S., Goyal, P., Kandambige, D., Sharifa, M., Maslamani, A. N. J., Kutabi, S. A., Saleh, I., Albshir, M. M., Almadhoun, M. K. I. K., et al. (2023) · Cureus · doi:10.7759/cureus.48655 · Cited by 16
Genetic Predisposition to Autoimmune Diseases Conferred by the Major Histocompatibility Complex
Taneja, V., Mangalam, A. K., & David, C. S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00027-7 · Cited by 10
Yao, Z., Yu, L., Ye, J., Li, P., Jiang, Y., & Chen, Y. (2020) · Indian Journal of Microbiology · doi:10.1007/s12088-020-00862-x · Cited by 14
Intestinal Bacteria Encapsulated by Biomaterials Enhance Immunotherapy
Liu, Y., Li, Z., Wu, Y., Jing, X., Li, L., & Fang, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.620170 · Cited by 12
Mazenc, A., Mervant, L., Maslo, C., Lencina, C., Bézirard, V., Levêque, M., Ahn, I., Alquier‐Bacquie, V., Naud, N., Héliès‐Toussaint, C., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102333 · Cited by 10
“Further, aberrant gut microbiota establishment with reduced diversity has been observed in newly diagnosed diabetic children [65,77,79], and most importantly, rescue of the gut barrier disruption by microbiota manipulation, has been shown to prevent low-grade intestinal inflammation, and more…”
Revelation of the sciences of traditional foods
Jia, Z., Zhang, B., Sharma, A., Kim, N. S., Purohit, S., Green, M. M., Roche, M. R., Holliday, E. G., & Chen, H. (2022) · Food Control · doi:10.1016/j.foodcont.2022.109392 · Cited by 11
Khan, T., & Raza, S. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230201144522 · Cited by 11
Santilli, A. D., Russell, J. T., Triplett, E. W., Whitehead, K. J., & Whitehead, D. C. (2019) · MedChemComm · doi:10.1039/c9md00301k · Cited by 11
Self-citationAssociation of Gut Microbiota and Diabetes Mellitus
Sowmiya, T., & Silambanan, S. (2022) · Current Diabetes Reviews · doi:10.2174/1573399819666221121104542 · Cited by 10
Chen, J., Wang, H., Bu, S., Cheng, X., Hu, X., Shen, M., & Zhuang, H. (2024) · BMC Oral Health · doi:10.1186/s12903-024-05089-6 · Cited by 11
The ketogenic diet in Parkinson’s disease: a potential therapeutic strategy
Pokora, B., Pokora, K., Binienda, A., & Fichna, J. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00799-2 · Cited by 9
“Firstly, it decreases the biosyn - thesis of essential vitamins like thiamine and folic acid, which may contribute to observed vitamin deficiencies [154 – 156].”
Prenatal and early life factors and type 1 diabetes
Abela, A. G., & Fava, S. (2022) · Endocrine · doi:10.1007/s12020-022-03057-0 · Cited by 9
A diabetes mellitus és a bélmikrobiom
Tomasics, G., Schandl, L., Polyák, A., & Winkler, G. (2023) · Orvosi Hetilap · doi:10.1556/650.2023.32788 · Cited by 10
Gut microbiome in the Graves’ disease: Comparison before and after anti-thyroid drug treatment
Jeong, C., Baek, H.-S., Bae, J., Hwang, N., Ha, J., Cho, Y., & Lim, D. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300678 · Cited by 11
Microbiota Modulation: Can Probiotics Prevent/Treat Disease in Pediatrics?
Szajewska, H. (2013) · Nestlé Nutrition Institute Workshop series · doi:10.1159/000351392 · Cited by 10
Rabbone, I., Traversi, D., Scaioli, G., Vallini, C., Carletto, G., Masante, I., Durazzo, M., Collo, A., Belci, P., Ferro, A., et al. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01555-z · Cited by 11
Blood microbiota composition in Iranian pre-diabetic and type 2 diabetic patients1
Ghaemi, F., Fateh, A., Sepahy, A. A., Zangeneh, M., Ghanei, M., & Siadat, S. D. (2021) · Human Antibodies · doi:10.3233/hab-210450 · Cited by 10
“Recent literature has linked gut microbiota composition with chronic diseases such as diabetes [23,36].”
Lomis, S. W. N. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000577 · Cited by 10
Tiwari, S., Kavitake, D., Suryavanshi, M. V., Shah, I. A., Devi, P. B., Reddy, G. B., & Shetty, P. H. (2024) · Food and Humanity · doi:10.1016/j.foohum.2024.100436 · Cited by 8
Effect of chewing betel nut on the gut microbiota of Hainanese
Li, Y., Yang, Y., Zhou, J., Huang, H., & Du, G. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258489 · Cited by 8
Jiang, W., Lu, G., Qiao, T., Yu, X., Luo, Q., Tong, J., Fan, S., Chai, L., Gao, D., Wang, R., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21463 · Cited by 9
“Bacteroides impair the intestinal mucosal barrier by reducing mucin synthesis and allowing toxins and bacterial metabolites to leak into the bloodstream, activating inflammatory responses [29].”
The impact of care on chimpanzee welfare: A comprehensive review
Angley, L. P., Vale, G. L., & Cronin, K. A. (2024) · Applied Animal Behaviour Science · doi:10.1016/j.applanim.2024.106272 · Cited by 10
Understanding of type 1 diabetes mellitus: what we know and where we go
Cheon, C. K. (2018) · Korean Journal of Pediatrics · doi:10.3345/kjp.2018.06870 · Cited by 11
Clostridia and Enteroviruses as Synergistic Triggers of Type 1 Diabetes Mellitus
Root-Bernstein, R. S., Chiles, K., Huber, J., Ziehl, A., Turke, M. J., & Pietrowicz, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098336 · Cited by 8
Fibroma (myxoma) molle in a hamster (Mesocricetus auratus).
West, W. L., Gaillard, E. T., & O'Connor, S. A. (2001) · PubMed · Cited by 9
Reduced phosphatidylcholine level in the intestinal mucus layer of prediabetic NOD mice
Mønsted, M. Ø., Bilgin, M., Kuzma, M., Pelantová, H., Pedersen, K., Tomášová, P., Nazmutdinova, A., Šedivá, B., Funda, D. P., Castro-Mejía, J. L., et al. (2023) · Apmis · doi:10.1111/apm.13302 · Cited by 9
“tridiaceae species [34], and decreased Ruminococcaceae [36,37] in human pre- and manifest T1D vs healthy controls.”
BackgroundGenomic Evolution of Lactic Acid Bacteria
Douglas, G. L., Azcárate-Peril, M. A., & Klaenhammer, T. R. (2015) · Wiley eBooks · doi:10.1002/9781118868386.ch3 · Cited by 8
Poddighe, D. (2025) · Diagnostics · doi:10.3390/diagnostics15101243 · Cited by 8
“Some peculiarities of the gut microbiome have been highlighted for both CD and T1DM: interestingly, fewer Firmicutes spp. and more Bacteroides spp. in the gut have been observed in both diseases according to some studies, even if they are not all concordant [94–97].”
Mechanisms of action and health benefits of probiotics: a comprehensive review
Alam, S. T., Rayhan, A. B. H., Ahmed, M. U., Khan, M. T., Jame, J. F., Islam, M. M., Raj, M. A. R., & Uddin, M. A. (2025) · Exploration of Drug Science · doi:10.37349/eds.2025.1008129 · Cited by 10
Influence of gut microbiota on the pediatric endocrine system and associated disorders
Shah, K., Khan, A. S., Kunwar, D., Jacob, S. R., Akbar, A., Singh, A., & Ahmed, M. M. H. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003099 · Cited by 8
Lifestyle Factors Affecting the Gut Microbiota’s Relationship with Type 1 Diabetes
Gülden, E. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1098-x · Cited by 9
Zhao, M., Xu, S., Cavagnaro, M. J., Zhang, W., & Shi, J. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.752250 · Cited by 7
Patel, N., Dinesh, S., & Sharma, S. (2023) · Current Diabetes Reviews · doi:10.2174/0115733998266653231005072450 · Cited by 8
Li, J., Xue, H., Qingqing, M., He, X., Ma, L., Shi, B., Sun, S., & Yao, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.576445 · Cited by 8
“Bacteria and symbiotic microflora in the gut can dynamically regulate the occurrence and development of autoimmune diseases (Ivanov et al., 2009; Brown et al., 2011; Lee et al., 2011; Scher et al., 2013; Cantarel et al., 2015).”
BackgroundZhao-Dong, L. I., Fang-Yuan, Q. I., & Li, F. (2022) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(21)60080-8 · Cited by 7
An Overview of the Roles of the Gut Microbiome in Obesity and Diabetes
Barlow, G. M., Lin, E. A., & Mathur, R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812019-4.00006-4 · Cited by 9
Bayesian Modeling of Microbiome Data for Differential Abundance AnalysisPreprint
Li, Q., Jiang, S., Koh, A. Y., Xiao, G., & Zhan, X. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1902.08741 · Cited by 11
“(2012) Poi ∏p j=1 Poi(yij ; siαij) • Brown et al. (2011) NB ∏p j=1 NB(yij ; siαij , φj) • • Zhang et al. (2017) ZIG ∏p j=1 πi(Yi·)I(yij = 0)+ • • • Paulson et al. (2013) (1− πi(Yi·))N ( log(yij + 1);αj , σ 2 j )”
InfluentialHaque, S., Bima, A. I. H., Babalghith, A. O., Jalal, N. A., Aldairi, A. F., Wahid, M., Ahmad, F., & Bantun, F. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00779-0 · Cited by 6
“These findings echo previous reports suggesting that an imbalance in the Firmicutes / Bacteroidota ratio and an expansion of Proteobacteria may reflect a pro-inflammatory gut environment conducive to T1D pathogenesis [7, 31].”
IGUDESMAN, D. A., Crandell, J., Corbin, K. D., Zaharieva, D. P., Addala, A., Thomas, J. M., Bulik, C. M., Pence, B. W., Pratley, R. E., Kosorok, M. R., et al. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.11.017 · Cited by 9
Viruses and Type 1 diabetes: a dynamic labile equilibrium
Schneider, D., & von Herrath, M. G. (2013) · Diabetes Management · doi:10.2217/dmt.13.17 · Cited by 7
Li, K., Cheng, X., Jin, R., Han, T., & Li, J. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15973 · Cited by 7
Probiotics as Potential Therapy in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD)
Monserrat-Mesquida, M., Bouzas, C., Mascaró, C. M., Tejada, S., & Sureda, A. (2023) · Fermentation · doi:10.3390/fermentation9040395 · Cited by 7
Linking epigenetic mechanisms of T cell dysfunction with pathophysiology of type 1 diabetes mellitus
Jabri, A., Elsalti, A., Alsharif, M., Alsharif, R., Abbad, T., Sibai, D., Taftafa, B., Mhannayeh, A., Khan, M. I., & Yaqinuddin, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1664255 · Cited by 5
Chi, F., Chen, K., Yin, Y., Hakovirta, J. R., & Saris, P. E. J. (2026) · Sustainable Microbiology · doi:10.1093/sumbio/qvag002 · Cited by 7
Consales, A., Toscano, L., Ceriotti, C., Tiraferri, V., Castaldi, S., & Giannì, M. L. (2024) · BMC Public Health · doi:10.1186/s12889-024-18497-8 · Cited by 8
Zeng, X., Ma, C., Fu, W., Xu, Y., Wang, R., Liu, D., Zhang, L., Hu, N., Li, D., & Li, W. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04514-9 · Cited by 5
“The diversity of gut microbiota and SCFAs in T1D is altered [22], suggesting the potentially important role of SCFAs in the aggravation of ischemic stroke in T1D; however, the exact role and mechanism through which SCFAs regulate neuro-inflammation remain unclear.”
Zheng, T., Li, X., & Xiang, H. (2025) · Endokrynologia Polska · doi:10.5603/ep.102030 · Cited by 6
Wu, Q., Xu, F., Yang, Y., Zhang, A., Sun, H., Yang, L. C., Zhao, S., Zeng, Y., Wang, M., Shi, S., et al. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118323 · Cited by 5
Nishigaki, A., Marchesi, J. R., & Previdelli, R. L. (2025) · Veterinary Sciences · doi:10.3390/vetsci12060541 · Cited by 5
Autoimmune Hepatitis in Hawai'i.
Kim, T. I., Kagihara, J. E., Tsai, N. C. S., & Roytman, M. M. (2015) · PubMed · Cited by 6
Root-Bernstein, R. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031797 · Cited by 6
Su, X., Hu, J., Huang, S. W., & Ning, K. (2014) · Scientific Reports · doi:10.1038/srep06393 · Cited by 5
“The commensal microorganisms living in our gut 20,21 , skin 22,23 and various other places have key roles in our physiology 24 , including our immune responses and metabolism, as well as in various human diseases 25 .”
BackgroundDoes the level of bacterial exposure in early life impact the risk of Type 1 diabetes?
Abela, A.-G., & Fava, S. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2013.814410 · Cited by 5
Oulghazi, S., Wegner, S. K., Spohn, G., Müller, N., Harenkamp, S., Stenzinger, A., Papayannopoulou, T., & Bonig, H. B. (2020) · Cells · doi:10.3390/cells9122597 · Cited by 5
“Common denominators include the appearance of Bacteroidales and extinction of Prevotella in diabetic NOD mice [53,54,56].”
BackgroundWu, Y., You, Q., Fei, J., & Wu, J. (2021) · Antonie van Leeuwenhoek · doi:10.1007/s10482-021-01632-5 · Cited by 5
Metadata
- Authors
- Brown, C. T., Davis-Richardson, A. G., Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Casella, G., Drew, J. C., Ilonen, J., Knip, M., Hyöty, H., Veijola, R., Simell, T., Simell, O., Neu, J., Wasserfall, C. H., Schatz, D., Atkinson, M. A., & Triplett, E. W.
- Affiliations
- University of Florida (US)
- University of Eastern Finland (FI)
- University of Helsinki (FI)
- Tampere University Hospital (FI)
- University of Oulu (FI)
- Turku University Hospital (FI)
- Corresponding author
- Triplett, Eric W.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-10-17
- Volume
- 6
- Issue
- 10
- Pages
- e25792
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3197175
- OpenAlex
- W2060915038
- Cited by
- 778
- References
- 48
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 53 · 2023: 60 · 2022: 69 · 2021: 73 · 2020: 66 · 2019: 69 · 2018: 68 · 2017: 59 · 2016: 55 · 2015: 49 · 2014: 47 · 2013: 38 · 2012: 22
- FWCI
- 14.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Tampere University Institutional Repository (Tampere University) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- type 1 diabetes, gut microbiota, autoimmunity, autoantibodies, metagenomics, bacterial gene function, carbohydrate metabolism, bacterial adhesion, flagella synthesis, butyrate production, short-chain fatty acids, mucin degradation, intestinal barrier integrity, lactate-utilizing bacteria, 16S rRNA
- MeSH terms
- Autoantibodies, Butyrates, Diabetes Mellitus, Type 1, Fatty Acids, Volatile, Humans, Mucins, RNA, Ribosomal, 16S, Autoimmunity, Case-Control Studies, Databases, Nucleic Acid, Gastrointestinal Tract, Metagenome, Metagenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.